Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Atypical Endometrial Hyperplasia

2 trials tracked for Atypical Endometrial Hyperplasia.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma Completed
  2. Phase 2 Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
PTEN IHC shows moderate diagnostic accuracy for differentiating atypical endometrial hyperplasia from non-atypical cases
OB/GYN & Women's Health Meta-analysis
PTEN IHC shows moderate diagnostic accuracy for differentiating atypical endometrial hyperplasia from non-atypical cases New test marker helps identify high risk uterine tissue
This meta-analysis of 2274 women evaluated the diagnostic accuracy of PTEN immunohistochemical markers in distinguishing atypical endometria…
A specific protein marker can help doctors tell the difference between precancerous and cancerous uterine tissues to avoid unnecessary surge…
Aug 2, 2026
Prolonged conservative treatment yields 58% complete response in endometrial hyperplasia and carcinoma
OB/GYN & Women's Health Meta-analysis
Prolonged conservative treatment yields 58% complete response in endometrial hyperplasia and carcinoma Longer conservative treatment may work for some uterine tissue conditions
This meta-analysis of 10 studies (846 women) assessed oncological outcomes of conservative treatment lasting more than 12 months in atypical…
Women with certain types of uterine cell growth may have options for longer, less invasive treatments under close medical supervision.
Aug 2, 2026